| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.09 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |